We are live on ! Find out more
IMVT icon

Immunovant
IMVT

215 hedge funds and large institutions have $2.75B invested in Immunovant in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 93 increasing their positions, 40 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

619% more call options, than puts

Call options by funds: $61.3M | Put options by funds: $8.52M

133% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 40

92% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 24

10% more funds holding

Funds holding: 196 → 215 (+19)

1% less capital invested

Capital invested by funds: $2.76B → $2.75B (-$14.3M)

7.63% less ownership

Funds ownership: 61.96% → 54.34% (-7.6%)

13% less funds holding in top 10

Funds holding in top 10: 8 → 7 (-1)

Holders
215
Holders Change
+19
Holders Change %
+9.69%
% of All Funds
2.65%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.09%
New
46
Increased
93
Reduced
40
Closed
24
Calls
$61.3M
Puts
$8.52M
Net Calls
+$52.8M
Net Calls Change
+$26.3M

Top Buyers

1
TCM
TCG Crossover Management
California
+$72.4M
2
Jennison Associates
Jennison Associates
New York
+$64.6M
3
FCM
Farallon Capital Management
California
+$39.7M
4
State Street
State Street
Massachusetts
+$19.4M
5
Bank of America
Bank of America
North Carolina
+$15M

Top Sellers

1
AC
Armistice Capital
New York
-$56.5M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$50.8M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$37.5M
4
Morgan Stanley
Morgan Stanley
New York
-$25.1M
5
SCM
Soleus Capital Management
Connecticut
-$22.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Westfield Capital Management
151
Westfield Capital Management
Massachusetts
$213K +$222K +8,581 New
Raymond James Financial
152
Raymond James Financial
Florida
$205K +$214K +8,257 New
Russell Investments Group
153
Russell Investments Group
United Kingdom
$202K +$24.6K +952 +13%
VPIM
154
Vanguard Personalized Indexing Management
California
$201K +$210K +8,100 New
Public Employees Retirement Association of Colorado
155
Public Employees Retirement Association of Colorado
Colorado
$166K – – –
AIP
156
Ameritas Investment Partners
Nebraska
$166K +$24.9K +963 +17%
Ensign Peak Advisors
157
Ensign Peak Advisors
Utah
$164K – – –
QT
158
Quantbot Technologies
New York
$133K +$45.5K +1,759 +49%
FIA
159
FNY Investment Advisers
New York
$111K +$12.9K +500 +13%
Nisa Investment Advisors
160
Nisa Investment Advisors
Missouri
$101K +$492 +19 +0.5%
GFM
161
GF Fund Management
China
$97.8K +$12.8K +493 +14%
KBC Group
162
KBC Group
Belgium
$87K – – –
Rockefeller Capital Management
163
Rockefeller Capital Management
New York
$82.4K +$68.5K +2,647 +396%
PNC Financial Services Group
164
PNC Financial Services Group
Pennsylvania
$72.1K +$3.18K +123 +4%
S
165
SignatureFD
Georgia
$70K – – –
Walleye Capital
166
Walleye Capital
New York
$67.8K +$70.7K +2,730 +273,000%
C
167
Covestor
United Kingdom
$64K +$3.75K +145 +6%
FFA
168
Farther Finance Advisors
California
$62.4K +$233 +9 +0.4%
KAS
169
Kemnay Advisory Services
New York
$60.1K +$51.9K +2,003 +481%
Royal Bank of Canada
170
Royal Bank of Canada
Ontario, Canada
$60K -$55.6K -2,148 -47%
Los Angeles Capital Management
171
Los Angeles Capital Management
California
$50.1K +$44.4K +1,713 +563%
CIAM
172
Caitong International Asset Management
Hong Kong
$46.8K +$48.8K +1,883 New
Osaic Holdings
173
Osaic Holdings
Arizona
$46.6K -$18.7K -723 -28%
Jones Financial Companies
174
Jones Financial Companies
Missouri
$35.5K +$28.7K +1,108 +297%
Carson Wealth (CWM LLC)
175
Carson Wealth (CWM LLC)
Nebraska
$35.4K -$3.6K -139 -9%
5 6
7
8 9

IMVT Hedge Fund Activity: Q1 2026 in Review

215 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q1 2026, worth a combined $2.75B — down 0.52% from $2.76B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new IMVT positions and 24 closed out — a net gain of 22 holders — while 93 added to existing stakes and 40 trimmed.

The largest buyer was TCG Crossover Management, adding an estimated $72.4M. The largest seller was Armistice Capital, cutting an estimated $56.5M.

  • 215 institutional investors held Immunovant (IMVT) as of Q1 2026, up from 196 in Q4 2025.
  • Funds reported $2.75B of Immunovant stock for Q1 2026, down 0.52% quarter-over-quarter.
  • 46 funds opened new Immunovant positions in Q1 2026 and 24 closed out, a net change of +22 holders.
  • The largest Immunovant buyer in Q1 2026 was TCG Crossover Management, an estimated $72.4M added.
  • The largest Immunovant seller in Q1 2026 was Armistice Capital, an estimated $56.5M sold.

Based on aggregated 13F filings for Q1 2026.